AI Science Tracker
EN

Identification of diagnostic gene biomarkers and immune infiltration in patients with diabetic kidney disease using machine learning strategies and bioinformatic analysis.

Department of Nephrology, The First Hospital of Jilin University, Changchun, China · 29 Sep 2022 · medicine

Discovery

Identification of diagnostic gene biomarkers and immune infiltration in patients with diabetic kidney disease using machine learning strategies and bioinformatic analysis.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: LASSO, SVM-RFE and random forest selected DUSP1 and PRKAR2B from training expression cohorts; separate GEO cohorts and kidney-tissue IHC were used for validation. Validation AUCs were 0.789 and 0.709, below training values. This is a narrow retrospective biomarker finding, not clinical diagnostic deployment.

Technology: Full text specifies the learned operation and how it supports the represented result.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Full text specifies the learned operation and how it supports the represented result.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.918657/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.